The FDA launched real-time clinical trials with AstraZeneca and Amgen. Here’s what RTCT is, why it matters, and what it actually demands from the clinical research ecosystem.
- What Is Clinical Trials Day? Why Technology Helps Research Rise
- DiMe's Navigator: Why Teams Still Stall On Digital Endpoints
- Why Are Life Science Companies So Poorly Prepared For RIM's Future?
- Digital Endpoints Are Ready. Clinical Development Isn't
- Why Clinical Trial Data Cleaning Must Go Continuous (And How To Do It)
- What Clinical Analytics Solutions Are Shaping Clinical Research
- Sites Are Building Their Own Tech – SCRS On What That Means
- Human-In-The-Loop In AI Validation And Control: From Principle To Practice
ON-DEMAND WEBINARS
Watch as clinical trial experts present how life science professionals can incorporate real-world data (RWD) and patient tokenization into their clinical development value streams.
The most difficult clinical research just became more challenging. Learn tactics on how teams can simplify oncology research while solving new and old issues.
Watch as speakers explore the experiences of sites conducting digital and hybrid trials, discussing the critical benefits of a change management strategy and a unified digital trial platform.
Discover essential insights on maintaining a high-quality Trial Master File (TMF) in a discussion about ICH GCP Essential Documents and the different regulations that apply to the TMF.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1081869356 data]( "How EDCs Are Changing The Game In Clinical Research")
How EDCs Are Changing The Game In Clinical ResearchExplore all things EDC in this article: what it is, how researchers can use it in clinical trials, its numerous benefits, and examples of how these translate into the real world.
-
![GettyImages-1163698800 patient ePRO]( "Patient-Centric Clinical Trials: The Power Of Choice")
Patient-Centric Clinical Trials: The Power Of ChoicePatient-centric trials, advocated by the FDA, focus on offering choices to improve engagement, diversity, and data quality. Explore how expanding patient choice can benefit clinical trials.
-
![GettyImages-1322205575 data ps]( "EDC For Mid-Study Changes In Medical Device Clinical Trials")
EDC For Mid-Study Changes In Medical Device Clinical TrialsIn this case study, discover how a company was pointed to an electronic data capture (EDC) system that was quick to adapt and easy to scale as the study changed.
-
![GettyImages-1257716223 fda guide]( "The Final DCT Guidance: I'm Not Mad At It")
The Final DCT Guidance: I'm Not Mad At ItExplore the FDA's 2024 final guidance on DCTs, including key updates that address previous concerns, affecting healthcare providers, sub-investigators, and sponsors.
-
![Mobile Device Management]( "Beyond The Pandemic: Why eCOAs Are Here To Stay")
Beyond The Pandemic: Why eCOAs Are Here To StayThe permanent adoption of eCOA is a natural step in the industry-wide effort to create a more patient-centric clinical trial experience. Learn more in the available blog.
-
![Data time clock GettyImages-454148967]( "Why Now Is The Right Time To Adopt eConsent")
Why Now Is The Right Time To Adopt eConsentAs much as eConsent helps staff, participants are also likely to prefer it over traditional paper methods. Explore the benefits of eConsent and some strategic steps sites can take right now to adopt the process.
-
![GettyImages-1313030664-doctor-office-tablet-futuristic-ai-connected]( "Technology Fragmentation Is One Of The Biggest Hidden Risks In Clinical Trials")
Technology Fragmentation Is One Of The Biggest Hidden Risks In Clinical TrialsReclaim your research day by reducing manual data entry. Learn how connecting operational and financial workflows eases administrative burdens and supports site sustainability.
-
![GettyImages-1022854264-partner-hands-shaking-lab-coats]( "Build Vs. Buy Vs. Partner In Life Sciences: Making The Right Call")
Build Vs. Buy Vs. Partner In Life Sciences: Making The Right CallDiscover when life sciences organizations should develop technology in-house, buy off-the-shelf solutions, or form strategic partnerships, exploring the costs and risks that come with each approach.
-
![rob-abbott]( "Enhancing The Accessibility And Affordability Of Healthcare")
Enhancing The Accessibility And Affordability Of HealthcareThe March/April 2025 issue of Value & Outcomes Spotlight explores the urgent global health crisis of accessibility and affordability, highlighting the nearly 2 billion individuals lacking essential medicines.
-
![Woman using cell phone 1263380081]( "Vaccine Trial Sees >90% eCOA Adherence")
Vaccine Trial Sees >90% eCOA AdherenceDiscover how we addressed vaccine trial challenges and drove remarkable success, achieving over 90% adherence to eCOA, ensuring active engagement from the trial participants, and yielding consistent, reliable trial data.
RECENT NEWSLETTERS
- 05.21.26 -- AI, HEOR, And Hidden Costs Reshaping Clinical Trials
- 05.14.26 -- AI, RWE, And The Systems Breaking Clinical Trials
- 05.07.26 -- How AI, ICH E6(R3) & RWD Are Reshaping Clinical Trials
- 05.02.26 -- Best Of April: AI In Clinical Trials — What Working
- 04.30.26 -- AI, RWE & Predictive Analytics Are Reshaping Trials
